Chief Financial Officer · Stoke Therapeutics, Inc. · Common Stock
Side
SELL
Value
$1,215
Shares
37
Price
$32.85
Executed
Mar 18, 2026
Disclosed
Mar 19, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 18 executedMar 19, 2026 disclosed
STOK · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Leggett Thomas filed this Form 4 reporting a open-market sale of STOK on Mar 18, 2026. It became public on Mar 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Leggett Thomascik:0001774690
Issuer
Stoke Therapeutics, Inc.cik:0001623526
Revision history · 0
No field has changed since this record was first ingested.
